Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QAV2
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 2 |
GO:0004721 | phosphoprotein phosphatase activity | 3 | 2 |
GO:0016787 | hydrolase activity | 2 | 2 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 2 |
GO:0016791 | phosphatase activity | 5 | 2 |
GO:0042578 | phosphoric ester hydrolase activity | 4 | 2 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 36 | 40 | PF00656 | 0.469 |
CLV_NRD_NRD_1 | 149 | 151 | PF00675 | 0.280 |
CLV_NRD_NRD_1 | 21 | 23 | PF00675 | 0.468 |
CLV_PCSK_KEX2_1 | 148 | 150 | PF00082 | 0.280 |
CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.468 |
CLV_PCSK_KEX2_1 | 213 | 215 | PF00082 | 0.389 |
CLV_PCSK_PC1ET2_1 | 148 | 150 | PF00082 | 0.168 |
CLV_PCSK_PC1ET2_1 | 213 | 215 | PF00082 | 0.389 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.280 |
CLV_PCSK_SKI1_1 | 21 | 25 | PF00082 | 0.453 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.240 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.473 |
DEG_APCC_DBOX_1 | 20 | 28 | PF00400 | 0.280 |
DOC_CDC14_PxL_1 | 206 | 214 | PF14671 | 0.393 |
DOC_CYCLIN_RxL_1 | 3 | 12 | PF00134 | 0.466 |
DOC_CYCLIN_yCln2_LP_2 | 189 | 195 | PF00134 | 0.350 |
DOC_CYCLIN_yCln2_LP_2 | 4 | 10 | PF00134 | 0.487 |
DOC_MAPK_gen_1 | 167 | 176 | PF00069 | 0.369 |
DOC_MAPK_gen_1 | 21 | 28 | PF00069 | 0.296 |
DOC_MAPK_gen_1 | 59 | 68 | PF00069 | 0.268 |
DOC_MAPK_JIP1_4 | 48 | 54 | PF00069 | 0.240 |
DOC_MAPK_MEF2A_6 | 21 | 30 | PF00069 | 0.280 |
DOC_MAPK_MEF2A_6 | 59 | 68 | PF00069 | 0.240 |
DOC_MAPK_NFAT4_5 | 21 | 29 | PF00069 | 0.280 |
DOC_PP4_FxxP_1 | 102 | 105 | PF00568 | 0.240 |
DOC_USP7_MATH_1 | 228 | 232 | PF00917 | 0.455 |
LIG_14-3-3_CanoR_1 | 21 | 27 | PF00244 | 0.325 |
LIG_14-3-3_CanoR_1 | 222 | 227 | PF00244 | 0.405 |
LIG_14-3-3_CanoR_1 | 41 | 49 | PF00244 | 0.276 |
LIG_BRCT_BRCA1_1 | 98 | 102 | PF00533 | 0.280 |
LIG_EH1_1 | 159 | 167 | PF00400 | 0.240 |
LIG_eIF4E_1 | 160 | 166 | PF01652 | 0.240 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.166 |
LIG_FHA_1 | 171 | 177 | PF00498 | 0.246 |
LIG_FHA_1 | 23 | 29 | PF00498 | 0.345 |
LIG_FHA_1 | 85 | 91 | PF00498 | 0.373 |
LIG_GBD_Chelix_1 | 161 | 169 | PF00786 | 0.280 |
LIG_GBD_Chelix_1 | 26 | 34 | PF00786 | 0.240 |
LIG_LIR_Apic_2 | 194 | 198 | PF02991 | 0.359 |
LIG_LIR_Apic_2 | 99 | 105 | PF02991 | 0.240 |
LIG_LIR_Nem_3 | 142 | 147 | PF02991 | 0.280 |
LIG_PTB_Apo_2 | 154 | 161 | PF02174 | 0.240 |
LIG_PTB_Phospho_1 | 154 | 160 | PF10480 | 0.240 |
LIG_REV1ctd_RIR_1 | 198 | 204 | PF16727 | 0.380 |
LIG_SH2_CRK | 195 | 199 | PF00017 | 0.251 |
LIG_SH2_NCK_1 | 195 | 199 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 160 | 163 | PF00017 | 0.240 |
LIG_SH2_STAT5 | 50 | 53 | PF00017 | 0.295 |
LIG_SH3_3 | 4 | 10 | PF00018 | 0.497 |
LIG_SH3_3 | 43 | 49 | PF00018 | 0.280 |
LIG_SUMO_SIM_anti_2 | 63 | 68 | PF11976 | 0.320 |
LIG_SUMO_SIM_par_1 | 120 | 125 | PF11976 | 0.300 |
LIG_SUMO_SIM_par_1 | 24 | 29 | PF11976 | 0.324 |
MOD_CK1_1 | 40 | 46 | PF00069 | 0.280 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.286 |
MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.295 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.387 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.280 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.263 |
MOD_GSK3_1 | 96 | 103 | PF00069 | 0.311 |
MOD_N-GLC_1 | 228 | 233 | PF02516 | 0.447 |
MOD_NEK2_1 | 30 | 35 | PF00069 | 0.240 |
MOD_NEK2_1 | 84 | 89 | PF00069 | 0.280 |
MOD_NEK2_1 | 96 | 101 | PF00069 | 0.195 |
MOD_PIKK_1 | 100 | 106 | PF00454 | 0.280 |
MOD_PKA_2 | 37 | 43 | PF00069 | 0.280 |
MOD_PKA_2 | 96 | 102 | PF00069 | 0.280 |
MOD_Plk_1 | 124 | 130 | PF00069 | 0.280 |
MOD_Plk_1 | 170 | 176 | PF00069 | 0.557 |
MOD_Plk_1 | 228 | 234 | PF00069 | 0.449 |
MOD_Plk_1 | 30 | 36 | PF00069 | 0.240 |
MOD_Plk_4 | 22 | 28 | PF00069 | 0.174 |
MOD_Plk_4 | 228 | 234 | PF00069 | 0.449 |
MOD_Plk_4 | 30 | 36 | PF00069 | 0.240 |
MOD_Plk_4 | 9 | 15 | PF00069 | 0.420 |
MOD_Plk_4 | 96 | 102 | PF00069 | 0.300 |
MOD_SUMO_rev_2 | 208 | 215 | PF00179 | 0.390 |
TRG_DiLeu_BaEn_1 | 151 | 156 | PF01217 | 0.295 |
TRG_DiLeu_BaLyEn_6 | 109 | 114 | PF01217 | 0.240 |
TRG_DiLeu_BaLyEn_6 | 19 | 24 | PF01217 | 0.358 |
TRG_ENDOCYTIC_2 | 159 | 162 | PF00928 | 0.240 |
TRG_ER_diArg_1 | 21 | 23 | PF00400 | 0.478 |
TRG_Pf-PMV_PEXEL_1 | 112 | 117 | PF00026 | 0.240 |
TRG_Pf-PMV_PEXEL_1 | 120 | 125 | PF00026 | 0.240 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HTD7 | Leptomonas seymouri | 30% | 83% |
A0A0S4ILH7 | Bodo saltans | 57% | 66% |
A0A3S7WY63 | Leishmania donovani | 97% | 100% |
A4HEM1 | Leishmania braziliensis | 28% | 82% |
C9ZJI3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 71% |
E9AH40 | Leishmania infantum | 97% | 100% |
E9AWL8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
M9PFN0 | Drosophila melanogaster | 34% | 68% |
O95476 | Homo sapiens | 27% | 98% |
Q1RMV9 | Bos taurus | 26% | 98% |
Q28HW9 | Xenopus tropicalis | 27% | 98% |
Q3B7T6 | Rattus norvegicus | 27% | 98% |
Q3TP92 | Mus musculus | 27% | 98% |
Q8BX07 | Mus musculus | 37% | 88% |
Q8JIL9 | Xenopus laevis | 27% | 98% |
V5BAV0 | Trypanosoma cruzi | 65% | 81% |